Real-world validity of randomized controlled phase III trials in newly diagnosed glioblastoma: to whom do the results of the trials apply?

BACKGROUND: The survival rates in population-based series of glioblastoma (GBM) differ substantially from those reported in clinical trials. This discrepancy may be attributed to that patients recruited to trials tend to be younger with better performance status. However, the proportion and characte...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neurooncol Adv
Autori principali: Skaga, Erlend, Skretteberg, Marthe Andrea, Johannesen, Tom Børge, Brandal, Petter, Vik-Mo, Einar O, Helseth, Eirik, Langmoen, Iver A
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2021
Soggetti:
Clinical Investigations
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7914075/
https://ncbi.nlm.nih.gov/pubmed/33665615
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdab008
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi